[Usefulness of reductive surgery for elderly advanced breast cancer with bone metastases - a case report].

Gan to kagaku ryoho. Cancer & chemotherapy 2014 Vol.41(12) p. 1912-4

Sakurai K, Fujisaki S, Nagashima S, Maeda T, Tomita R, Suzuki S, Hara Y, Hirano T, Enomoto K, Amano S

관련 도메인

Abstract

We report the case of an elderly, advanced breast cancer patient with multiple bone metastases. Breast reduction surgery was useful for this patient. The patient was an 81-year-old woman who had a breast lump. A core needle biopsy for breast cancer led to a diagnosis of invasive ductal carcinoma. The mucinous carcinoma was estrogen receptor (ER) nd progesterone receptor (PgR) positive and HER2/neu negative. Due to patient complications, it was not possible to treat with chemotherapy. The patient was administrated aromatase inhibitors (AI) and zoledronic acid hydrate. However, the AI treatment was not effective, and so she was administered toremifene. Toremifene treatment was effective for 6 months, after which she received fulvestrant. Fulvestrant treatment maintained stable disease (SD)for 14 months. After 14 months of fulvestrant treatment, serum concentrations of the tumor markers CA15-3, CEA, and BCA225 increased. We therefore decided to perform surgical breast reduction surgery. The pathological diagnosis from the surgically resected specimen was mucinous carcinoma, positive for ER and HER2, and negative for PgR. After surgery, serum concentrations of the tumor markers decreased. Following surgery, the patient was administrated lapatinib plus denosumab plus fulvestrant. The patient remains well, without bone metastases, 2 years and 6 months after surgery.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
해부 breast 유방 dict 6
시술 breast reduction 유방성형술 dict 2
해부 bone scispacy 1
해부 serum scispacy 1
약물 estrogen C0014939
estrogens
scispacy 1
약물 progesterone C0033308
progesterone
scispacy 1
약물 zoledronic acid hydrate C1960914
Zoledronic acid hydrate
scispacy 1
약물 toremifene C0076836
toremifene
scispacy 1
약물 fulvestrant C0935916
fulvestrant
scispacy 1
약물 lapatinib C1506770
lapatinib
scispacy 1
약물 denosumab C1690432
denosumab
scispacy 1
약물 zoledronic acid scispacy 1
질환 breast cancer C0006142
Malignant neoplasm of breast
scispacy 1
질환 ductal carcinoma C1176475
Ductal Carcinoma
scispacy 1
질환 mucinous carcinoma C0007130
Mucinous Adenocarcinoma
scispacy 1
질환 tumor C0027651
Neoplasms
scispacy 1
질환 breast cancer patient scispacy 1
질환 invasive ductal carcinoma scispacy 1
질환 PgR. scispacy 1
기타 patient scispacy 1
기타 estrogen receptor scispacy 1
기타 PgR → progesterone receptor scispacy 1
기타 HER2/neu scispacy 1
기타 aromatase scispacy 1
기타 CEA scispacy 1
기타 BCA225 scispacy 1
기타 HER2 scispacy 1

MeSH Terms

Adenocarcinoma, Mucinous; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Combined Modality Therapy; Female; Humans

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문